Skip to main content
Premium Trial:

Request an Annual Quote

Incyte and Genomic Health to Collaborate on Consumer Genomic Applications

NEW YORK, May 7 - Incyte has signed a collaboration with Palo Alto, Calif., startup  Genomic Health to develop consumer health applications for genomics, the companies said Monday.

Genomic Health is a privately-held applied genomics company founded by Incyte co-founder Randy Scott, Genentech scientists Joffre Baker and Steven Shak; organizational development expert Gene Early, and Patrick Terry, a health care consumer advocate. Incyte participated in the latest round of financing for this company.

Under the agreement, Genomic Health will have access to Incyte's LifeSeq Gold and BioKnowledge databases as well as other Incyte intellectual property. Incyte said Genomic Health would pay a similar fee to that paid by other licensees to its databases and information, although the parties did not disclose further financial terms of the agreement.

Other Investors in Genomic Health include Kleiner Perkins Caufield & Byers; Versant Ventures; Baker Tisch Investments, and CHL Medical Partners.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.